Amcor Business Sale Proceeds decreased by 75.0% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.00M to $2.00M. Over 2 years (FY 2022 to FY 2025), Business Sale Proceeds shows relatively stable performance with a 0.0% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | -$1.00M | $19.00M | $4.00M | $366.00M | $18.00M | $4.00M | $7.00M | $1.00M | $27.00M | $1.00M | $6.00M | $2.00M | $9.00M | $28.00M | $8.00M | $2.00M |
| QoQ Change | — | — | — | >999% | -78.9% | >999% | -95.1% | -77.8% | +75.0% | -85.7% | >999% | -96.3% | +500.0% | -66.7% | +350.0% | +211.1% | -71.4% | -75.0% |
| YoY Change | — | — | — | — | — | — | -5.3% | +0.0% | -98.1% | — | +50.0% | -75.0% | -14.3% | +100.0% | -66.7% | >999% | +33.3% | +0.0% |